Transcriptional Program of Bone Morphogenetic Protein-2-induced Epithelial and Smooth Muscle Differentiation of Pluripotent Human Embryonal Carcinoma Cells
Overview
Molecular Biology
Authors
Affiliations
Pluripotent human embryonal carcinoma NTera2/cloneD1 (NT2/D1) cells respond to multiple vertebrate patterning factors and offer a unique model system to investigate the signaling events associated with lineage determination and cell differentiation. Here, we define the temporal changes in global gene expression patterns in NT2/D1 cells upon treatment with bone morphogenetic protein-2 (BMP-2). Exposure to BMP-2 rapidly induced the expression of several transcription factors involved in establishing non-neural ectodermal fate followed by the appearance of epithelial-specific markers. Subsequent loss of stem cell markers was coupled to gene expression changes associated with decreased proliferative activity. Temporal clustering of gene expression patterns revealed a concurrent down-regulation of multiple transcripts involved in neurogenesis, neurite outgrowth, and axonal guidance, suggesting that the BMP-mediated differentiation process involves pro-epithelial as well as anti-neurogenic mechanisms. In addition, increased expression of smooth muscle markers both by gene expression and immunohistochemistry was detected. Several neural crest markers were induced preceding such a differentiation, compatible with a neural crest origin of NT2/D1-derived smooth muscle cells. Comparison of changes in transcript expression between BMP-2-induced epithelial versus all-trans-retinoic acid (ATRA)-induced neural differentiation revealed potential candidates for regulation of BMP-2 signaling and suppression of neural fate by BMP-2. This study suggests that BMP-2-induced differentiation of NT2/D1 cells provides a powerful assay to study early human epithelial and smooth muscle development.
Gordeeva O Cells. 2019; 8(12).
PMID: 31771212 PMC: 6953027. DOI: 10.3390/cells8121500.
Li W, Liu W, Kakoki A, Wang R, Adebali O, Jiang Y J Biol Chem. 2019; 294(15):5914-5922.
PMID: 30808711 PMC: 6463700. DOI: 10.1074/jbc.RA119.007861.
Li Y, Pu J, Zhang B Exp Ther Med. 2014; 8(4):1131-1136.
PMID: 25187810 PMC: 4151643. DOI: 10.3892/etm.2014.1916.
Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.
Giuliano C, Freemantle S, Spinella M Curr Cancer Ther Rev. 2014; 2(3):255-270.
PMID: 24482633 PMC: 3904303. DOI: 10.2174/157339406777934681.
Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells.
Abada P, Howell S PLoS One. 2014; 9(1):e87444.
PMID: 24475288 PMC: 3903721. DOI: 10.1371/journal.pone.0087444.